Export 2747 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
N. AP, “Clinical Trials Referral Resource. Clinical trials with prillyl alcohol.”, Oncology, vol. 11, pp. 1817-23, 1997.
N. AP, “Clinical trials referral resource. High priority trials.”, Oncology, vol. 11, pp. 1144-50, 1997.
N. AP, “Clinical Trials Referral Resource. Lung cancer.”, Oncology, vol. 11, pp. 1686-94, 1997.
A. - R. Eye Diseas AREDS), Gensler, G., Gore-Langton, R., Kurinij, N., Lindblad, A., and Sowell, A., “The Effect of Five-Year Zinc Supplementation on Serum Zinc, Serum Cholesterol and Hematocrit in Persons Randomly Assigned to Treatment Group in the Age-Related Eye Disease Study: AREDS Report No. 7”, J Nutrition, vol. 132, pp. 697-702, 2002.
A. - R. Eye Diseas AREDS), “A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9”, Arch Ophthalmol, vol. 119, pp. 1439-1452, 2001.
E. Y. Chew, Clemons, T., Sangiovanni, J. Paul, Danis, R., Domalpally, A., McBee, W., Sperduto, R., and Ferris, F. L., “The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).”, Ophthalmology, vol. 119, no. 11, pp. 2282-9, 2012.
S. N. Al-Holou, Tucker, W. R., Agrón, E., Clemons, T. E., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.”, Ophthalmology, vol. 123, no. 4, pp. 916-7, 2016.
E. Y. Chew, Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., and Garfinkel, R., “Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.”, Ophthalmology, vol. 121, no. 2, pp. 535-44, 2014.
A. Aref, Scott, I., Oden, N., Ip, M., Blodi, B., VanVeldhuisen, P., and Group, T. S. C. O. R. E. Stud, “Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15”, JAMA Ophthalmol, 2015.
A. A. Aref, Scott, I. U., Oden, N. L., Ip, M. S., Blodi, B. A., and VanVeldhuisen, P. C., “Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.”, JAMA Ophthalmol, vol. 133, no. 9, pp. 1022-9, 2015.
A. A. Aref, Scott, I. U., VanVeldhuisen, P. C., King, J., Ip, M. S., Blodi, B. A., and Oden, N. L., “Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial”, JAMA Ophthalmol, vol. 139, no. 12, pp. 1285-1291, 2021.
J. Armstrong, Davis, M. D., Gangnon, R. E., Lee, L. - Y., Klein, R., Klein, B. E., Milton, R. C., Ferris, F. L., Hubbard, L. D., and Group, A. - R. Eye Diseas, “Illustration of the AMD severity scale from the Age-Related Eye Disease Study”, 2004.
R. Arnon, Kerkar, N., Davis, M. K., Anand, R., Yin, W., and González-Peralta, R. P., “Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience.”, Pediatr Transplant, vol. 14, no. 6, pp. 796-805, 2010.
R. Arnon, Kerkar, N., Davis, M., Anand, R., Yin, W., González-Peralta, R., and Group, T. Studies of, “Liver Transplantation in Children with Metabolic Diseases: The Studies of Pediatric Liver Transplantation Experience”, Pediatr Transplant, vol. 14, pp. 796-805, 2010.
L. AS, “The effects of treatment noncompliance on power in a 2x2 factorial design,”, J Biopharm Stat, vol. 6, pp. 263-70, 1996.
L. AS, “Murine OKT4A immunosuppression in cadaver donor renal allograft recipients.”, Transplantation., vol. 69, pp. 1243-51, 1997.
L. AS and TE, C., “Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity: AREDS Report No. 14”, Arch Ophthalmol, vol. 123, pp. 1207-1214, 2005.
E. Atallah, Bylow, K., Troy, J., and W, S., “Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)”, Curr Hematol Malig Rep, vol. 9, pp. 57-65, 2014.
E. Atallah, Bylow, K., Troy, J., and Saber, W., “Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).”, Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.
M. A. Atkinson, Martz, K., Warady, B. A., and Neu, A. M., “Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS.”, Pediatr Nephrol, vol. 25, no. 9, pp. 1699-706, 2010.
M. Atkinson, Martz, K., Warady, B., and Neu, A. M., “Risk for Anemia in Pediatric Chronic Kidney Disease Patients: A Report of NAPRTCS”, Pediatric Nephrology, vol. 25, pp. 1699-1706, 2010.
R. L. Atmar, Bernstein, D. I., Winokur, P., Frey, S. E., Angelo, L. S., Bryant, C., Ben-Yedidia, T., Roberts, P. C., Sahly, H. M. El, and Keitel, W. A., “Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial.”, Vaccine, vol. 41, no. 16, pp. 2716-2722, 2023.
R. L. Atmar, Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H., Ramani, S., Hill, H., Ferreira, J., and Graham, D. Y., “Determination of the 50% Human Infectious Dose for Norwalk Virus”, J Infect Dis, vol. 209, pp. 1016-1022, 2014.
R. L. Atmar, Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., and Mendelman, P. M., “Norovirus Vaccine Against Experimental Human Norwalk Virus Illness”, N Engl J Med, vol. 365, pp. 2178-2187, 2011.
R. L. Atmar, Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H., Ramani, S., Hill, H., Ferreira, J., and Graham, D. Y., “Determination of the 50% human infectious dose for Norwalk virus.”, J Infect Dis, vol. 209, no. 7, pp. 1016-22, 2014.